In the current study, immunohistochemical staining of α-SMA was elevated in the BLM group, whereas treatment with PIC, Vit D, or PIC-Vit D led to a significant decline in α-SMA expression in comparison with the BLM group. This evidence concerns the gene ACTA1 and Bloom syndrome.